The Foundation for Innovative New Diagnostics (FIND) announced last Friday that it has awarded grants to a number of companies to address the urgent diagnostic needs for hepatitis C virus (HCV). These grants will be used to conduct feasibility studies of various technologies that could transform HCV testing at [...]
GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel(tafenoquine) for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection. Read [...]
Mologic and Newcastle University launch BReD diagnostic for blackgrass resistance at Cereals Bedfordshire and Newcastle, UK, 13 June 2018: Mologic Ltd, a developer of personalised diagnostics, and Newcastle University, today announced they have developed an on-farm blackgrass resistance diagnostic (BReD). The one-step, rapid lateral flow product for detecting glutathione transferase (AmGSTF1) [...]
Mologic Signs Agreements with Medisur and Peripal to Distribute PERIPLEX POC Diagnostic in Europe Bedfordshire, UK, 1st May 2018: Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®, a rapid point-of-care (POC) [...]
Test will expand the range of diagnostic options available to guide treatment of Plasmodium Vivax Seattle, Washington, April 17, 2018—PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria. “This test will be a [...]
QUALITY SYSTEM ADMINISTRATOR MOLOGIC LTD IS SEEKING A QUALITY SYSTEM ADMINISTRATOR TO WORK WITH ITS IVD MEDICAL DEVICES DEVELOPMENT AND MANUFACTURING PROGRAMMES. Responsibilities and Duties. The role is based at Mologic Ltd (Thurleigh), an innovative healthcare diagnostics company. You will work with and report directly to the Quality & Regulatory [...]
Barbara Fallowfield, Commercial Manager of Mologic was recently interviewed by Anna Macdonald of Technology Networks where they discussed issues clinicians face whilst under pressure to prescribe antibiotics, and how a recent partnership between Fraunhofer UK, and Mologic can help tackle those issues through the development of a novel in vitro diagnostic assay. This assay [...]
On the 19th of February, Mologic were visited by Minister of State and NE Beds MP @AlistairBurtUK to hear all about our malaria diagnostics research. He was especially interested from the perspective of the Department for International Development.
Fraunhofer and Mologic partner on point-of-care diagnosis and antibiotic susceptibility test for UTIs Project awarded £900K NHS development grant through SBRI Healthcare Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance Bedfordshire and Glasgow, UK, 20 February, 2018: Mologic Ltd, which develops powerful, personalised diagnostics to improve [...]
Fraunhofer and Mologic partner on point-of-care diagnosis and antibiotic susceptibility test for UTIs Project awarded £900K NHS development grant through SBRI Healthcare Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance Bedfordshire and Glasgow, UK, 20 February, 2018: Mologic Ltd, which develops powerful, personalised diagnostics to improve [...]